Neuropeptide Regulation of Mitosis
1994; Wiley; Volume: 739; Issue: 1 Linguagem: Inglês
10.1111/j.1749-6632.1994.tb19827.x
ISSN1749-6632
AutoresIllana Gozes, Douglas E. Brenneman, G. Lilling, Ariane Davidson, Terry W. Moody,
Tópico(s)Pancreatic function and diabetes
ResumoAnnals of the New York Academy of SciencesVolume 739, Issue 1 p. 253-261 Neuropeptide Regulation of Mitosis ILLANA GOZES, ILLANA GOZES Department of Clinical Biochemistry Sackler School of Medicine Tel Aviv University Tel Aviv, IsraelSearch for more papers by this authorDOUGLAS E. BRENNEMAN, DOUGLAS E. BRENNEMAN Section on Developmental and Molecular Pharmacology National Institute of Child Health and Human DevelopmentSearch for more papers by this authorGILA LILLING, GILA LILLING Department of Clinical Biochemistry Sackler School of Medicine Tel Aviv University Tel Aviv, IsraelSearch for more papers by this authorARIANE DAVIDSON, ARIANE DAVIDSON Department of Clinical Biochemistry Sackler School of Medicine Tel Aviv University Tel Aviv, IsraelSearch for more papers by this authorTERRY W. MOODY, TERRY W. MOODY Division of Cancer Prevention and Control National Cancer Institute National Institutes of Health Rockville, Maryland 20850Search for more papers by this author ILLANA GOZES, ILLANA GOZES Department of Clinical Biochemistry Sackler School of Medicine Tel Aviv University Tel Aviv, IsraelSearch for more papers by this authorDOUGLAS E. BRENNEMAN, DOUGLAS E. BRENNEMAN Section on Developmental and Molecular Pharmacology National Institute of Child Health and Human DevelopmentSearch for more papers by this authorGILA LILLING, GILA LILLING Department of Clinical Biochemistry Sackler School of Medicine Tel Aviv University Tel Aviv, IsraelSearch for more papers by this authorARIANE DAVIDSON, ARIANE DAVIDSON Department of Clinical Biochemistry Sackler School of Medicine Tel Aviv University Tel Aviv, IsraelSearch for more papers by this authorTERRY W. MOODY, TERRY W. MOODY Division of Cancer Prevention and Control National Cancer Institute National Institutes of Health Rockville, Maryland 20850Search for more papers by this author First published: October 1994 https://doi.org/10.1111/j.1749-6632.1994.tb19827.xCitations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Nilsson, J., A. M. Euler & C. J. Dalsgaard 1985. Stimulation of connective tissue cell growth by substance P and substance K. Nature. 315: 61–63. 2 Cossu, G., M. G. Cusella-De Angelis, M. I. Senni, L. De Angelis, E. Vivarelli, S. Vella, M. Bouche, C. Boitani & M. Molinaro 1989. Adrenocorticotropin is a specific mitogen for mammalian myogenic cells. Dev. Biol. 131: 331–336. 3 Zohar, M. & Y. Salomon 1993. Mechanism of action of melanocortin peptides: Possible role in astrocyte regulation. J. Mol. Neurosci. 4: 55–62. 4 Miller, R. P., F. Husain, M. Svenssen & S. Lohin 1977 Enhancement of [3H-methyl]thymidine incorporation and replication of rat chondrocytes grown in tissue culture. Endocrinology 100: 1365–1375. 5 Carter, D. A., C. Kum Fai & D. Murphy 1993 Neurohypophysial peptides as regulators of growth and development: A review. J. Mol. Neurosci. 4: 21–28. 6 Giladi, E., S. R. Nagalla & E. Spindel 1993. Molecular cloning and characterization of receptors for the mammalian bombesin-like peptides. J. Mol. Neurosci. 4: 41–54. 7 Staley, J., D. H. Coy, R. T. Jensen & T. W. Moody 1993. Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cancer cell lines. J. Mol. Neurosci. 4: 29–40. 8 Mitsuo, K. & J. P. Schwartz 1993. Chronic treatment of newborn rats with naltrexone alters astrocyte production of nerve growth factor. J. Mol. Neurosci. 4: 21–28. 9 Denis-Donini, S. 1989. Expression of dopaminergic phenotypes in the mouse olfactory bulb induced by the calcitonin gene-related peptide. Nature. 339: 701–703. 10 Nawa, H., S. Nakanishi & P. H. Patterson 1991. Recombinant cholinergic differentiation factor (leukemia inhibitory factor) regulates sympathetic neuron phenotypes by alteration in the size and amounts of neuropeptides mRNAs. J. Neurochem. 56: 2147–2150. 11 Gozes, I. & D. E. Brenneman 1989. VIP: Molecular biology and neurobiological function. Mol. Neurobiol. 3: 201–236. 12 Gozes, I. & D. E. Brenneman 1993. Neuropeptides as growth factors in general and VIP in particular. J. Mol. Neurosci. 4: 1–10. 13 Bodner, M., M. Fridkin & I. Gozes 1985. VIP and PHM-27 sequences are located on two adjacent exons in the human genome. Proc. Natl. Acad. Sci. USA. 82: 3548–3551. 14 Giladi, E., Y. Shani & I. Gozes 1990. The complete structure of the rat VIP gene. Mol. Brain Res. 7: 261–267. 15 Theriault, Y., Y. Boulanger & S. St.-Pierre 1991. Structural determination of the vasoactive intestinal peptide by two-dimensional H-NMR spectroscopy. Biopolymers. 31: 459–464. 16 O'Donnell, M., R. J. Garippa, N. C. O'Neill, D. R. Bolin & J. M. Cottrell 1991. Structure-activity studies of vasoactive intestinal peptide. J. Biol. Chem. 5: 6389–6392. 17 Gozes, I., E. Meltzer, S. Rubinraut, D. E. Brenneman & M. Fridkin 1989. Vasoactive intestinal peptide potentiates sexual behavior: Inhibition by novel antagonist. Endocrinology. 125: 2945–2949. 18 Gozes, I., S. K. McCune, L. Jacobson, D. Warren, T. W. Moody, M. Fridkin & D. E. Brenneman 1991. An antagonist to vasoactive intestinal peptide affects cellular functions in the central nervous system. J. Pharmacol. Exp. Ther. 257: 959–966. 19 Bolin, D. R., J. Cottrell, R. Garippa, N. O'Neill, B. Simko & M. O'Donnell 1993. Structure-activity studies of vasoactive intestinal peptide (VIP): Cyclic disulfide analogues. Int. J. Pept. Protein Res. 41: 124–132. 20 Ishihara, T., R. Shigemoto, K. Mori, K. Takahashi & S. Nagata 1992. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron. 8: 811–819. 21 Sreedharan, S. P., D. R. Patel, J. X. Huang & E. J. Goetzl 1993. Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide. Biochem. Biophys. Res. Commun. 193: 546–553. 22 Couvineau, A., C. Rouyer-Fessard, D. Darmoul, J.-J. Maoret, I. Carrero, E. Ogier-Denis & M. Labourthe 1994 Cloning of a common VIP-PACAP receptor from human intestine. Submitted for publication. 23 Lutz, E. M., W. J. Sheward, K. M. West, J. A. Morrow, G. Fink & A. J. Harmar 1993 The VIP2 receptor: Molecular characterization of a cDNA encoding a novel receptor for vasoactive intestinal peptide. FEBS Lett. 334: 3–8. 24 Spengler, D., C. Waeber, C. Pnataloni, F. Holsboer, J. Bockaert, P. H. Seeburg & L. Journot 1993. Differential signal transduction by five splice variants of PACAP receptor. Nature. 365: 170–175. 25 Pisegna, J. R. & S. A. Wank 1993. Molecular cloning and functional expression of the pituitary adenylate cyclase activating polypeptide type I receptor. Proc. Natl. Acad. Sci. USA. 90: 6345–6349. 26 Masau, Y., T. Ohtaki, Y. Masuda, M. Tsuda & M. Fujino 1992. Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): Comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections. Brain Res. 575: 113–123. 27 Rorstad, O. P., I. Wanke, D. H. Coy, A. Fournier & M. Huang 1990. Selectivity for binding peptide analogues to vascular receptors for vasoactive intestinal peptide. Mol. Pharmacol. 37: 971–977. 28 Brenneman, D. E. & L. E. Eiden 1986. Vasoactive intestinal peptide and electrical activity influence neuronal survival. Proc. Natl. Acad Sci. USA. 83: 1159–1162. 29 Fatatis, A., L. A. Holtzclaw, R. Avidor, D. E. Brenneman & J. T. Russell 1994. Vasoactive intestinal peptide increases intracellular calcium in astroglia: Synergism with α-adrenergic receptors. Proc. Natl. Acad. Sci. USA. 91: 2036–2040. 30 Gozes, I. & M. Fridkin 1992. A fatty neuropeptide: Potential drug for noninvasive impotence treatment in a rat model. J. Clin. Invest. 90: 810–814. 31 Gozes, I., A. Reshef, D. Salah, S. Rubinraut & M. Fridkin 1994. Stearyl-norleucine-VIP: A novel VIP analogue for noninvasive impotence treatment. Endocrinology. 134: 2121–2125. 32 Brenneman, D. E., T. Nicol, D. Warren & L. M. Bowers 1990. Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogen. J. Neurosci. Res. 25: 386–394. 33 Pincus, D. W., E. M. DiCicco-Bloom & I. Black 1990. Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature. 343: 564–567. 34 Pincus, D. W., E. M. DiCicco-Bloom & I. Black 1990. Vasoactive intestinal peptide regulation of neuroblast mitosis: Role of cAMP. Brain Res. 514: 355–357. 35 Pincus, D. W., E. M. DiCicco-Bloom & I. Black 1991. Role of voltage-sensitive calcium channels in mitogenic stimulation of neuroblasts. Brain Res. 553: 211–214. 36 Gressens, P., J. M. Hill, I. Gozes, M. Fridkin & D. E. Brenneman 1993. Growth factor function of vasoactive intestinal peptide in whole cultured mouse embryos. Nature. 362: 155–158. 37 O'Dorisio, S. M., D. J. Fleshmann, S. J. Qualman & T. M. O'Dorisio 1992. Vasoactive intestinal peptide: Autocrine growth factor in neuroblastoma. Regul. Pept. 37: 213–226. 38 Pence, J. C. & N. A. Shorter 1993. The autocrine function of vasoactive intestinal peptide on human neuroblastoma cell growth and differentiation. Arch. Surg. 128: 591–595. 39 Wollman, Y., G. Lilling, M. N. Goldstein, M. Fridkin & I. Gozes 1993. Vasoactive intestinal peptide: A growth promoter in neuroblastoma cells. Brain Res. 624: 339–441. 40 Rabier, M. J., E. M. Farber & D. Wilkinson 1993. Neuropeptides modulate leukotriene B4 mitogenicity toward cultured human keratinocytes. J. Invest. Dermatol. 100: 132–136. 41 Gozes, Y., D. E. Brenneman, M. Fridkin, R. Asofsky & I. Gozes 1991. A VIP antagonist distinguishes VIP receptors on spinal cord cells and lymphocytes. Brain Res. 540: 319–321. 42 Jin, J.-G., K. S. Murthy, J. R. Grider & G. M. Makhlouf 1993. Activation of distinct cAMP- and cGMP-dependent pathways by relaxant agents in isolated gastric muscle cells. Gastrointest. Liver Physiol. 27: G470–G477. 43 Scholar, E. M. & S. Paul 1991. Stimulation of tumor cell growth by vasoactive intestinal peptide. Cancer. 67: 1561–1564. 44 Hoosein, N. M., C. J. Logothetis & L. W. Chung 1993. Differential effects of peptide hormones bombesin, vasoactive intestinal polypeptide and somatostatin analog RC-160 on invasive capacity of human prostatic carcinoma cells. J. Urol. 149: 1209–1213. 45 Moody, T. W., F. Zia, A. L. Goldstein, P. H. Naylor, E. Sarin, D. E. Brenneman, A. M. C. Koros, J. C. Reubi, L. Y. Korman, M. Fridkin & I. Gozes 1992. VIP analogues inhibit small cell lung cancer growth. Biomed. Res. 13(Suppl. 2): 131–135. 46 Moody, T. W., F. Zia, M. Draoui, D. E. Brenneman, M. Fridkin, A. Davidson & I. Gozes 1993. A novel VIP antagonist inhibits non-small cell lung cancer growth. Proc. Natl. Acad. Sci. USA. 90: 4345–4349. 47 Maruno, K. & S. I. Said 1993. Small-cell lung carcinoma: Inhibition of proliferation by vasoactive intestinal peptide and helodermin and enhancement of inhibition by antibombesin antibody. Life Sci. 52: PL267–271. 48 Banker, G. A. 1980. Trophic interactions between astroglial cells and hippocampal neurons in culture. Science. 209: 809–810. 49 Brenneman, D. E., E. A. Neale, G. A. Foster, S. D'Autremont & G. L. Westbrook 1987. Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide. J. Cell Biol. 104: 1603–1610. 50 Brenneman, D. E., M. Schultzberg, T. Bartfai & I. Gozes 1992. Cytokine regulation of neuronal survival. J. Neurochem. 58: 454–460. 51 Giulian, D., J. Woodward, D. G. Young, J. F. Krebs & L. B. Lachman 1988. Interleukin-1 injected into mammalian brain stimulates astrogliosis and neovascularization. J. Neurosci. 8: 2485–2490. 52 Agoston, D. V., L. E. Eiden, D. E. Brenneman & I. Gozes 1991. Spontaneous electrical activity regulates vasoactive intestinal peptide expression in dissociated spinal cord cultures. Mol. Brain Res. 10: 235–240. 53 Csillag, A., K. Zilles, A. Schleicher & F. Hajos 1992. Matching localization of immunoreactive VIP and VIP receptor in the visual cortex. Neurosci. Soc. Abstr. 18: 1451. 54 Fink, J. S., M. Verhave, K. Walton, G. Mandel & R. H. Goodman 1991. Cyclic-AMP and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J. Biol. Chem. 266: 3882–3887. 55 Rosselin, G., A. Anteunis, A. Astesano, C. Boissard, P. Gali, G. Hejblum & J. C. Marie 1988. Regulation of vasoactive intestinal peptide receptor. Ann. N. Y. Acad. Sci. 527: 220–237. 56 Ceccatelli, S., R. Cortes & T. Hökfelt 1991. Effect of reserpine and colchicine on neuropeptide mRNA levels in the rat hypothalamic paraventricular nucleus. Mol. Brain Res. 9: 57–69. Citing Literature Volume739, Issue1Models of Neuropeptide ActionOctober 1994Pages 253-261 ReferencesRelatedInformation
Referência(s)